ABIVAX Société Anonyme
ABVX
$82.36
-$3.52-4.09%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/16/2025
-
Ticker Report
9/15/2025
-
TipRanks Financial Blog
9/15/2025
-
Zolmax
9/15/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/13/2025
-
GuruFocus
9/13/2025
-
MarketBeat
9/12/2025
-
GuruFocus
9/12/2025
-
Globe Newswire
9/12/2025
-
MarketBeat
9/12/2025
-
The Fly
9/12/2025
-
MarketBeat
9/11/2025
-
MarketBeat
9/11/2025
-
MarketBeat
9/11/2025
-
TipRanks Financial Blog
9/10/2025
-
TipRanks Financial Blog
9/9/2025
-
GuruFocus
9/9/2025
-
TipRanks Financial Blog
9/8/2025
-
GuruFocus
9/8/2025
-
GuruFocus
9/8/2025
-
GuruFocus
9/8/2025
-
Globe Newswire
9/8/2025
-
MarketBeat
9/7/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, September 8, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
33 1 53 83 09 63
Address
7-11 boulevard Haussmann
Paris, 75009
Paris, 75009
Country
Year Founded
Business Description
Sector
--
Industry
--
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in...
more